David Drachman, MBA

Senior Territory Manager at CORCYM
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 1 ratings
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Steve Moore

I had the pleasure of being on the same team with Dave at AtriCure. Dave's passion, clinical knowledge, and hard work enabled him to quickly build solid relationships leading to a tremendous increase in sales revenue. He was instrumental in opening numerous new AtriCure accounts throughout the territory and quickly became a top performer. I'm lucky to have worked with Dave. He's a very talented individual and a great asset to AtriCure!

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United Kingdom
    • Medical Equipment Manufacturing
    • 100 - 200 Employee
    • Senior Territory Manager
      • Nov 2021 - Present

      CORCYM is a new, independent, global medical-device company focused on the structural heart area. CORCYM is a new, independent, global medical-device company focused on the structural heart area.

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Market Development
      • Jul 2019 - Nov 2020

      From transcatheter and surgical valves to structural interventions, the Abbott Structural Heart portfolio spans a wide range of life-changing technologies. Our vision and leadership in mitral and tricuspid solutions enable us to push the boundaries in developing solutions for undertreated conditions. Moreover the depth and breadth of our experience—paired with our proven therapy solutions—provide the means to help you address structural heart patient needs at every stage of living. From transcatheter and surgical valves to structural interventions, the Abbott Structural Heart portfolio spans a wide range of life-changing technologies. Our vision and leadership in mitral and tricuspid solutions enable us to push the boundaries in developing solutions for undertreated conditions. Moreover the depth and breadth of our experience—paired with our proven therapy solutions—provide the means to help you address structural heart patient needs at every stage of living.

    • United Kingdom
    • Medical Equipment Manufacturing
    • 700 & Above Employee
    • Territory Manager
      • Mar 2017 - May 2019

      LivaNova is a global leader in cardiac surgery based on many factors, including our established leadership position in heart-lung machines and recognition as the world’s #1 cardiopulmonary bypass company. Our advanced solutions have made significant contributions to open-heart surgery outcomes for many patients. Notably, we offer the only sutureless valve for aortic surgery. LivaNova is a global leader in cardiac surgery based on many factors, including our established leadership position in heart-lung machines and recognition as the world’s #1 cardiopulmonary bypass company. Our advanced solutions have made significant contributions to open-heart surgery outcomes for many patients. Notably, we offer the only sutureless valve for aortic surgery.

    • United States
    • Medical Equipment Manufacturing
    • 700 & Above Employee
    • Territory Manager
      • Jun 2008 - Oct 2016

      AtriCure is your partner in atrial fibrillation solutions. Our research and rigorous atrial fibrillation clinical trials have led to innovations in ablation technology to treat atrial fibrillation with lasting solutions. Our Synergy Ablation System is the first and only device approved by the Food and Drug Administration for the surgical treatment of persistent atrial fibrillation and longstanding persistent atrial fibrillation in patients undergoing open heart procedures simultaneously. In addition, we pioneered the AtriClip®, a left atrial appendage occlusion, device that is the most widely implanted for left atrial appendage management worldwide. It is our passion to collaborate with surgeons to make surgeries like the Maze IV simpler to perform and be reproducible by more doctors around the world. Through continued commitment to product innovation and education grounded in clinical science, we’re working to reduce the global atrial fibrillation epidemic. Show less

Education

  • Xavier University - Williams College of Business
    MBA
    2011 - 2014
  • University of Miami College of Arts & Sciences
    BA, Economics and Political Science
    2004 - 2008

Community

You need to have a working account to view this content. Click here to join now